In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...
Unveiling a new chapter in the understanding of human genetics, scientists have discovered a hidden geometric code within our ...
Dr. Katz's research shows how important it is for all breast cancer survivors to have access to genetic testing services, ...
Arabidopsis thaliana was always an unlikely candidate for the limelight. But 25 years ago, the diminutive thale cress ...
A new genomic method has enabled multiple people with rare conditions to receive diagnoses that were previously unattainable ...
Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...
Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
How they’re doing it: The new company, called Preventive, is being formed to research so-called “heritable genome editing,” ...
A better understanding of protein glycosylation offers insights into disease mechanisms and helps improve therapeutic medicines.
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
A naturally occurring gene called Cyclin A2 (CCNA2), which turns off after birth in humans, can actually make new, functioning heart cells and help the heart repair itself from injury, including a ...